New oncological approaches using immune checkpoint inhibitors aim to reinvigorate lymphocytes against the tumor. The prognosis of cancer has been significantly improved by these treatments, which nonetheless lead to a new spectrum of immune-related side effects. The most frequent are skin rash, colitis, thyroid dysfunction, hypophysitis, hepatitis and pneumonitis. Early detection of these toxicities is crucial to determine the etiology and to introduce a temporary immunosuppressive therapy, allowing resolution of toxicity in most of cases. A multidisciplinary team is essential for optimal management.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
immune checkpoint
8
checkpoint inhibitors
8
[side effects
4
effects immune
4
inhibitors diagnosis
4
diagnosis management]
4
management] oncological
4
oncological approaches
4
approaches immune
4
inhibitors aim
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!